Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.
Permanent link to this recordhttp://hdl.handle.net/10754/671111
MetadataShow full item record
AbstractBeta-amyloid (Aβ) has been recognized as an early trigger in the pathogenesis of Alzheimer's disease (AD) leading to synaptic and cognitive impairments. Aβ can alter neuronal signaling through interactions with nicotinic acetylcholine receptors (nAChRs), contributing to synaptic dysfunction in AD. The three major nAChR subtypes in the hippocampus are composed of α7-, α4β2-, and α3β4-nAChRs. Aβ selectively affects α7- and α4β2-nAChRs, but not α3β4-nAChRs in hippocampal neurons, resulting in neuronal hyperexcitation. However, how nAChR subtype selectivity for Aβ affects synaptic function in AD is not completely understood. Here, we showed that Aβ associated with α7- and α4β2-nAChRs but not α3β4-nAChRs. Computational modeling suggested that two amino acids in α7-nAChRs, arginine 208 and glutamate 211, were important for the interaction between Aβ and α7-containing nAChRs. These residues are conserved only in the α7 and α4 subunits. We therefore mutated these amino acids in α7-containing nAChRs to mimic the α3 subunit and found that mutant α7-containing receptors were unable to interact with Aβ. In addition, mutant α3-containing nAChRs mimicking the α7 subunit interact with Aβ. This provides direct molecular evidence for how Aβ selectively interacted with α7- and α4β2-nAChRs, but not α3β4-nAChRs. Selective coactivation of α7- and α4β2-nAChRs also sufficiently reversed Aβ-induced AMPA receptor dysfunction, including Aβ-induced reduction of AMPA receptor phosphorylation and surface expression in hippocampal neurons. Moreover, costimulation of α7- and α4β2-nAChRs reversed the Aβ-induced disruption of long-term potentiation. These findings support a novel mechanism for Aβ's impact on synaptic function in AD, namely, the differential regulation of nAChR subtypes.
CitationRoberts, J. P., Stokoe, S. A., Sathler, M. F., Nichols, R. A., & Kim, S. (2021). Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid–induced synaptic dysfunction. Journal of Biological Chemistry, 296, 100402. doi:10.1016/j.jbc.2021.100402
SponsorsWe thank members of the Kim laboratory for their generous support. In particular, we thank Rosaline Danzman, Luis Gomez Wulschner, Thomas McMillan, and Caleb Wipf for initiating the project. We also thank Drs Michael Tamkun, Jozsef Vigh, Frederic Hoerndli, and Susan Tsunoda for helpful discussion and providing reagents. We specially thank Dr SeungBeom Hong at King Abdullah University of Science and Technology for his help in structural analysis.
PubMed Central IDPMC7961090
CollectionsPublications Acknowledging KAUST Support
- The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4).
- Authors: Pym LJ, Buckingham SD, Tsetlin V, Boyd CA, Sattelle DB
- Issue date: 2007 Oct 29
- A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides.
- Authors: Liu Q, Huang Y, Xue F, Simard A, DeChon J, Li G, Zhang J, Lucero L, Wang M, Sierks M, Hu G, Chang Y, Lukas RJ, Wu J
- Issue date: 2009 Jan 28
- A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
- Authors: Liu Q, Xie X, Emadi S, Sierks MR, Wu J
- Issue date: 2015 Oct
- A novel nicotinic mechanism underlies β-amyloid-induced neuronal hyperexcitation.
- Authors: Liu Q, Xie X, Lukas RJ, St John PA, Wu J
- Issue date: 2013 Apr 24
- Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
- Authors: Kroker KS, Moreth J, Kussmaul L, Rast G, Rosenbrock H
- Issue date: 2013 Jul